Browsing: Uncategorized
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of Qiming Venture Partners and clinical-stage biopharmaceutical leader, successfully listed on the Nasdaq on August 5, 2026 Beijing time. Attovia Therapeutics (Nasdaq: ATTO) issued shares at a price of
Germany’s DAX stock index reached a historic milestone on Tuesday, surpassing 20,000 points for the first time despite the country grappling with significant economic challenges. The index, which tracks 40 of Germany’s largest publicly traded companies, has defied domestic economic sentiment,
PARIS, Sept. 13, 2023 /PRNewswire/ — After the brilliantly successful launch of the new version of Artprice.com by Artmarket at the beginning of September, our initial analyses and statistics show an overwhelmingly positive response from our customers and new users